Murthy et al. showed that a combined therapy of pentoxifylline and anti-TNF antibody in DSS-induced colitis mice can be beneficial to limit the side effects associated with anti-TNF antibody treatment alone [37]. The gene discussed is TNF; the disease is colitis.